$0.01 Earnings Per Share Expected for MINDBODY, Inc. (MB) This Quarter

Wall Street brokerages expect that MINDBODY, Inc. (NASDAQ:MB) will report earnings per share (EPS) of $0.01 for the current quarter, Zacks Investment Research reports. Eight analysts have issued estimates for MINDBODY’s earnings. The lowest EPS estimate is $0.00 and the highest is $0.02. MINDBODY reported earnings per share of ($0.04) during the same quarter last year, which suggests a positive year over year growth rate of 125%. The business is expected to issue its next earnings report on Wednesday, February 14th.

On average, analysts expect that MINDBODY will report full-year earnings of ($0.01) per share for the current year, with EPS estimates ranging from ($0.02) to $0.00. For the next year, analysts anticipate that the business will post earnings of $0.20 per share, with EPS estimates ranging from $0.06 to $0.36. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for MINDBODY.

MINDBODY (NASDAQ:MB) last posted its earnings results on Thursday, October 26th. The technology company reported $0.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.05. MINDBODY had a negative return on equity of 8.39% and a negative net margin of 9.26%. The firm had revenue of $46.60 million for the quarter, compared to analysts’ expectations of $45.59 million. During the same period in the previous year, the firm earned ($0.09) earnings per share. The business’s revenue was up 32.0% compared to the same quarter last year.

Several equities analysts have recently issued reports on the company. KeyCorp raised MINDBODY from a “sector weight” rating to an “overweight” rating and boosted their target price for the company from $16.95 to $32.00 in a research note on Friday, September 22nd. BidaskClub cut MINDBODY from a “strong-buy” rating to a “buy” rating in a research note on Thursday. UBS reissued a “buy” rating and set a $40.00 target price (up from $34.00) on shares of MINDBODY in a research note on Thursday, November 9th. Roth Capital reissued a “buy” rating and set a $31.50 target price on shares of MINDBODY in a research note on Thursday, September 28th. Finally, Jefferies Group began coverage on MINDBODY in a research note on Thursday, August 24th. They set a “hold” rating and a $26.00 target price on the stock. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $32.54.

In other news, CFO Brett T. White sold 10,000 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $26.56, for a total value of $265,600.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Richard Lee Stollmeyer sold 17,739 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $26.54, for a total value of $470,793.06. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 955,594 shares of company stock worth $25,273,140 and sold 178,717 shares worth $5,260,296. 8.22% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BNP Paribas Arbitrage SA grew its stake in shares of MINDBODY by 2,171.3% in the second quarter. BNP Paribas Arbitrage SA now owns 4,111 shares of the technology company’s stock worth $112,000 after acquiring an additional 3,930 shares during the last quarter. Legal & General Group Plc grew its stake in shares of MINDBODY by 4.1% in the first quarter. Legal & General Group Plc now owns 4,218 shares of the technology company’s stock worth $116,000 after acquiring an additional 166 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of MINDBODY by 49.8% in the second quarter. Oppenheimer Asset Management Inc. now owns 5,046 shares of the technology company’s stock worth $137,000 after acquiring an additional 1,678 shares during the last quarter. Quantbot Technologies LP grew its stake in shares of MINDBODY by 75.5% in the second quarter. Quantbot Technologies LP now owns 6,902 shares of the technology company’s stock worth $187,000 after acquiring an additional 2,970 shares during the last quarter. Finally, Credit Suisse AG purchased a new stake in shares of MINDBODY in the first quarter worth $220,000. 90.16% of the stock is currently owned by hedge funds and other institutional investors.

MINDBODY (NASDAQ:MB) traded down $0.45 on Thursday, hitting $30.15. The stock had a trading volume of 446,888 shares, compared to its average volume of 433,914. The company has a debt-to-equity ratio of 0.06, a quick ratio of 9.20 and a current ratio of 9.20. MINDBODY has a 52-week low of $19.65 and a 52-week high of $36.25.

COPYRIGHT VIOLATION WARNING: “$0.01 Earnings Per Share Expected for MINDBODY, Inc. (MB) This Quarter” was originally published by Week Herald and is the property of of Week Herald. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://weekherald.com/2017/12/07/0-01-earnings-per-share-expected-for-mindbody-inc-mb-this-quarter.html.

About MINDBODY

MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with local business subscribers on its platform. The Company’s subscribers provide a range of wellness services to active consumers. Its integrated software and payments platform helps business owners in the wellness services industry run, market and build their businesses.

Get a free copy of the Zacks research report on MINDBODY (MB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MINDBODY Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply